Prognostic Significance of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Esophageal and Gastric Cancer

被引：0
|
作者：
Chan, David S.
Reid, Tom D.
Blackshaw, Guy
Crosby, Tom
Lewis, Wyn G.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [41] Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
    Erickson, Britt K.
    Zeybek, Burak
    Santin, Alessandro D.
    Fader, Amanda N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 57 - 64
  • [42] Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
    Riecke, Kerstin
    Witzel, Isabell
    BREAST CARE, 2020, 15 (06) : 579 - 585
  • [43] Draft recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer will decrease HER2 positivity rates
    Johnson, Eric
    Gulbahce, Evin
    CANCER RESEARCH, 2018, 78 (04)
  • [44] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma
    Togami, Shinichi
    Sasajima, Yuko
    Oi, Takateru
    Ishikawa, Mitsuya
    Onda, Takashi
    Ikeda, Shun-Ichi
    Kato, Tomoyasu
    Tsuda, Hitoshi
    Kasamatsu, Takahiro
    CANCER SCIENCE, 2012, 103 (05) : 926 - 932
  • [46] Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)
    Seyedmirzaei, Homa
    Keshavarz-Fathi, Mahsa
    Razi, Sepideh
    Gity, Masoumeh
    Rezaei, Nima
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (05) : 1235 - 1244
  • [47] Emerging drugs targeting human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer
    Awada, Gil
    Gombos, Andrea
    Aftimos, Philippe
    Awada, Ahmad
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (01) : 91 - 101
  • [48] Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges
    Laokulrath, Natthawadee
    Gudi, Mihir
    Salahuddin, Syed Ahmed
    Chong, Angela Phek Yoon
    Ding, Cristine
    Iqbal, Jabed
    Leow, Wei Qiang
    Tan, Benjamin Yongcheng
    Tse, Gary
    Rakha, Emad
    Tan, Puay Hoon
    HISTOPATHOLOGY, 2024, 85 (03) : 371 - 382
  • [49] An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
    Elshazly, Ahmed M.
    Gewirtz, David A.
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 472 - 486
  • [50] Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer
    Kim, Min Chong
    Kang, Su Hwan
    Choi, Jung Eun
    Bae, Young Kyung
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 484 - 497
12345